GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndrome.-论文-万方医学网

第一作者： Lacramioara,Botezatu

第一单位： Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

作者： Lacramioara,Botezatu ^[1] ; Lars C,Michel ^[1] ; Hideki,Makishima ^[2] ; Thomas,Schroeder ^[3] ; Ulrich,Germing ^[3] ; Rainer,Haas ^[3] ; Bert,van der Reijden ^[4] ; Anne E,Marneth ^[4] ; Saskia M,Bergevoet ^[4] ; Joop H,Jansen ^[4] ; Bartlomiej,Przychodzen ^[2] ; Marcin,Wlodarski ^[5] ; Charlotte,Niemeyer ^[5] ; Uwe,Platzbecker ^[6] ; Gerhard,Ehninger ^[6] ; Ashwin,Unnikrishnan ^[7] ; Dominik,Beck ^[7] ; John,Pimanda ^[7] ; Eva,Hellström-Lindberg ^[8] ; Luca,Malcovati ^[9] ; Jacqueline,Boultwood ^[10] ; Andrea,Pellagatti ^[10] ; Elli,Papaemmanuil ^[11] ; Philipp,Le Coutre ^[12] ; Jaspal,Kaeda ^[12] ; Bertram,Opalka ^[1] ; Tarik,Möröy ^[13] ; Ulrich,Dührsen ^[1] ; Jaroslaw,Maciejewski ^[2] ; Cyrus,Khandanpour ^[14]

作者单位： Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany. ^[1] Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA. ^[2] Department of Hematology and Oncology, University Hospital Düsseldorf, Düsseldorf, Germany. ^[3] Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. ^[4] Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany. ^[5] Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany. ^[6] Lowy Cancer Research Centre and Prince of Wales Clinical School, University of New South Wales, Sydney, Australia. ^[7] Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden. ^[8] Department of Molecular Medicine, University of Pavia, and Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. ^[9] Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom. ^[10] Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom. ^[11] Medical Department with Focus on Hematology/Oncology Charite Berlin, Campus Virchow-Klinikum, Berlin, Germany. ^[12] Institut de Recherches Cliniques de Montréal (IRCM), Hematopoiesis and Cancer Research Unit, and Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, Canada. ^[13] Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany. Electronic address: Cyrus.Khandanpour@uk-essen.de. ^[14]

主题词成年人(Adult);老年人(Aged);等位基因(Alleles);氨基酸取代(Amino Acid Substitution);骨髓(Bone Marrow);队列研究(Cohort Studies);细胞遗传学分析(Cytogenetic Analysis);DNA结合蛋白质类(DNA-Binding Proteins);女(雌)性(Female);基因频率(Gene Frequency);基因型(Genotype);人类(Humans);男(雄)性(Male);中年人(Middle Aged);骨髓增生异常综合征(Myelodysplastic Syndromes);全血细胞减少(Pancytopenia);表型(Phenotype);多态性, 单核苷酸(Polymorphism, Single Nucleotide);预后(Prognosis);存活率分析(Survival Analysis);转录因子(Transcription Factors)

DOI 10.1016/j.exphem.2016.04.001

PMID 27080012

发布时间 2018-11-13

检索历史清除

GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndrome.

Experimental hematology

相似文献

Experimental hematology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndrome.

Experimental hematology

相似文献

Experimental hematology

相关期刊

检索历史清除